Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
In December 2019, a novel coronavirus (SARS-CoV-2) was first isolated from Wuhan city, China and within three months, the global community was challenged with a devastating pandemic. The rapid spread of the virus challenged diagnostic laboratories to rapidly develop molecular diagnostic methods. As...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12471
- Acceso en línea:
- https://www.sciencedirect.com/science/article/abs/pii/S1386653220301268?via%3Dihub
http://hdl.handle.net/20.500.12010/12471
https://doi.org/10.1016/j.jcv.2020.104384
- Palabra clave:
- COVID-19
SARS-CoV-2
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
LOD
- Rights
- License
- Acceso restringido